Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

DR info

Clinical trials : 7 / Drugs : 8 - (DrugBank : 3) / Drug target genes : 8 - Drug target pathways : 16

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

3,4-diaminopyridine
   Lahey Clinic
      2001   -   NCT00872950   United States
   Ricardo Maselli
      2017   -   NCT03062631   United States
   Vern C. Juel, M.D.
      2012   -   NCT01765140   United States
Albuterol
   Mayo Clinic
      2010   Phase 1   NCT01203592   United States
Alloex exosomes
   The Foundation for Orthopaedics and Regenerative Medicine
      2025   Phase 1   NCT07226726   Antigua and Barbuda;United States
Amifampridine phosphate
   Catalyst Pharmaceuticals, Inc.
      2015   -   NCT02189720   United States
ARGX-119
   argenx
      2024   Phase 1   NCT06436742   Canada;France;Italy;Spain;United Kingdom;United States